LBA65 First-line nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) in patients (pts) with unresectable malignant pleural mesothelioma (MPM): 3-year update from CheckMate 743 - Peters, S; Scherpereel, A; Cornelissen, R (Annals of Oncology, 2021)
et al.